While the song’s backstory might be staged on its cover - a recreation of the moment Harry Houdini was supposedly passed a ...

John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...

Fintel reports that on July 7, 2025, Oppenheimer initiated coverage of Pulse Biosciences (NasdaqCM:PLSE) with a Outperform recommendation. Analyst Price Forecast Suggests 74.21% Downside As of March ...

James Cameron recently called out Christopher Nolan’s Oscar-winning film “Oppenheimer” for being “a moral cop out” in the ...

Filmmaker James Cameron calls "Oppenheimer" a "moral cop-out" for avoiding bombing aftermath scenes, as he develops his own ...

James Cameron addressed Christopher Nolan's Oppenheimer, saying that the film was a 'moral cop out' due to a lack of certain ...

Nvidia Corporation (NASDAQ:NVDA) is one of the top 10 picks from Harvard University’s stock portfolio. As of the end of Q1 ...

A Los Alamos home was featured in one of the biggest summer blockbusters. Now, a group is trying to open it up for the public ...

Mission: Impossible - The Final Reckoning's next target is Aquaman 2's box office haul in China. Read on for more.

U.S. men's tennis star Ben Shelton is on the verge of a big win in the second round of Wimbledon on Thursday. While Shelton ...

The Thomas Crown Affair' has added Kenneth Branagh to its cast, bringing aboard Oscar winner Charles Roven to produce.

Cameron isn't the first critic to raise that particular issue with Oppenheimer; Spike Lee, to name one critic, has said, "If ...